These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 28816009

  • 1. Protective Effect of Atazanavir Sulphate Against Pulmonary Fibrosis In Vivo and In Vitro.
    Song S, Ji Y, Zhang G, Zhang X, Li B, Li D, Jiang W.
    Basic Clin Pharmacol Toxicol; 2018 Feb; 122(2):199-207. PubMed ID: 28816009
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Long-term oral atazanavir attenuates myocardial infarction-induced cardiac fibrosis.
    Zhang G, Zhang X, Li D, Tian J, Jiang W.
    Eur J Pharmacol; 2018 Jun 05; 828():97-102. PubMed ID: 29605419
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Soluble epoxide hydrolase inhibitor AUDA decreases bleomycin-induced pulmonary toxicity in mice by inhibiting the p38/Smad3 pathways.
    Dong XW, Jia YL, Ge LT, Jiang B, Jiang JX, Shen J, Jin YC, Guan Y, Sun Y, Xie QM.
    Toxicology; 2017 Aug 15; 389():31-41. PubMed ID: 28694203
    [Abstract] [Full Text] [Related]

  • 7. High-Mobility Group Box 1 Mediates Epithelial-to-Mesenchymal Transition in Pulmonary Fibrosis Involving Transforming Growth Factor-β1/Smad2/3 Signaling.
    Li LC, Li DL, Xu L, Mo XT, Cui WH, Zhao P, Zhou WC, Gao J, Li J.
    J Pharmacol Exp Ther; 2015 Sep 15; 354(3):302-9. PubMed ID: 26126535
    [Abstract] [Full Text] [Related]

  • 8. Phenylbutyric acid inhibits epithelial-mesenchymal transition during bleomycin-induced lung fibrosis.
    Zhao H, Qin HY, Cao LF, Chen YH, Tan ZX, Zhang C, Xu DX.
    Toxicol Lett; 2015 Jan 05; 232(1):213-20. PubMed ID: 25455454
    [Abstract] [Full Text] [Related]

  • 9. Regulation of Transforming Growth Factor-β/Smad-mediated Epithelial-Mesenchymal Transition by Celastrol Provides Protection against Bleomycin-induced Pulmonary Fibrosis.
    Divya T, Velavan B, Sudhandiran G.
    Basic Clin Pharmacol Toxicol; 2018 Aug 05; 123(2):122-129. PubMed ID: 29394529
    [Abstract] [Full Text] [Related]

  • 10. Tanshinone IIA ameliorates bleomycin-induced pulmonary fibrosis and inhibits transforming growth factor-beta-β-dependent epithelial to mesenchymal transition.
    Tang H, He H, Ji H, Gao L, Mao J, Liu J, Lin H, Wu T.
    J Surg Res; 2015 Jul 05; 197(1):167-75. PubMed ID: 25911951
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Sulindac has strong antifibrotic effects by suppressing STAT3-related miR-21.
    Zhou X, Li YJ, Gao SY, Wang XZ, Wang PY, Yan YF, Xie SY, Lv CJ.
    J Cell Mol Med; 2015 May 05; 19(5):1103-13. PubMed ID: 25704671
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Mushroom Inonotus sanghuang alleviates experimental pulmonary fibrosis: Implications for therapy of pulmonary fibrosis.
    Su X, Liu K, Xie Y, Zhang M, Wu X, Zhang Y, Wang J.
    Biomed Pharmacother; 2021 Jan 05; 133():110919. PubMed ID: 33202282
    [Abstract] [Full Text] [Related]

  • 17. Protective effects of GHK-Cu in bleomycin-induced pulmonary fibrosis via anti-oxidative stress and anti-inflammation pathways.
    Ma WH, Li M, Ma HF, Li W, Liu L, Yin Y, Zhou XM, Hou G.
    Life Sci; 2020 Jan 15; 241():117139. PubMed ID: 31809714
    [Abstract] [Full Text] [Related]

  • 18. Forsythoside A regulates pulmonary fibrosis by inhibiting endothelial-to-mesenchymal transition and lung fibroblast proliferation via the PTPRB signaling.
    Zhang Q, Zhang B, Yang F, Hu Y, Fan R, Wang M, Chen S.
    Phytomedicine; 2024 Jul 25; 130():155715. PubMed ID: 38788399
    [Abstract] [Full Text] [Related]

  • 19. Dasatinib Suppresses TGFβ-Mediated Epithelial-Mesenchymal Transition in Alveolar Epithelial Cells and Inhibits Pulmonary Fibrosis.
    Kanemaru R, Takahashi F, Kato M, Mitsuishi Y, Tajima K, Ihara H, Hidayat M, Wirawan A, Koinuma Y, Hayakawa D, Yagishita S, Ko R, Sato T, Harada N, Kodama Y, Nurwidya F, Sasaki S, Niwa SI, Takahashi K.
    Lung; 2018 Oct 25; 196(5):531-541. PubMed ID: 29926178
    [Abstract] [Full Text] [Related]

  • 20. The role of high mobility group box1 in pulmonary fibrosis.
    Hamada N, Maeyama T, Kawaguchi T, Yoshimi M, Fukumoto J, Yamada M, Yamada S, Kuwano K, Nakanishi Y.
    Am J Respir Cell Mol Biol; 2008 Oct 25; 39(4):440-7. PubMed ID: 18441281
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.